Kestra Advisory Services LLC Purchases 12,561 Shares of GE HealthCare Technologies Inc. $GEHC

Kestra Advisory Services LLC lifted its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 24.1% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 64,641 shares of the company’s stock after buying an additional 12,561 shares during the quarter. Kestra Advisory Services LLC’s holdings in GE HealthCare Technologies were worth $4,601,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the business. Auto Owners Insurance Co grew its stake in shares of GE HealthCare Technologies by 9,525.4% in the fourth quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock valued at $278,725,000 after acquiring an additional 33,629,559 shares in the last quarter. Norges Bank acquired a new stake in GE HealthCare Technologies in the 4th quarter worth about $596,024,000. Barrow Hanley Mewhinney & Strauss LLC bought a new stake in GE HealthCare Technologies in the 4th quarter valued at about $533,655,000. Cynosure Group LLC grew its position in shares of GE HealthCare Technologies by 21,045.4% during the 4th quarter. Cynosure Group LLC now owns 4,365,462 shares of the company’s stock worth $358,055,000 after purchasing an additional 4,344,817 shares in the last quarter. Finally, Boston Partners acquired a new position in shares of GE HealthCare Technologies during the 3rd quarter worth approximately $287,627,000. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Up 4.0%

NASDAQ:GEHC opened at $65.70 on Friday. The firm’s 50 day simple moving average is $63.65 and its 200 day simple moving average is $72.03. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95. GE HealthCare Technologies Inc. has a one year low of $58.75 and a one year high of $89.77. The company has a market cap of $29.89 billion, a PE ratio of 15.72, a P/E/G ratio of 1.72 and a beta of 0.72.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.08). The business had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The company’s revenue was up 7.4% compared to the same quarter last year. During the same quarter last year, the company posted $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, research analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Friday, July 24th will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Friday, July 24th. GE HealthCare Technologies’s dividend payout ratio is presently 3.35%.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the company. The Goldman Sachs Group reissued a “neutral” rating on shares of GE HealthCare Technologies in a research report on Monday, June 8th. HSBC cut their target price on GE HealthCare Technologies from $100.00 to $90.00 in a research report on Thursday, April 30th. JPMorgan Chase & Co. reduced their target price on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a report on Thursday, April 30th. Wells Fargo & Company decreased their price target on GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating on the stock in a research report on Thursday, April 30th. Finally, BTIG Research reaffirmed a “buy” rating and issued a $75.00 price target on shares of GE HealthCare Technologies in a research note on Monday. Ten analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to data from MarketBeat.com, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and an average target price of $79.38.

Insiders Place Their Bets

In related news, Director Kevin Lobo purchased 10,000 shares of GE HealthCare Technologies stock in a transaction on Friday, May 22nd. The shares were purchased at an average price of $64.18 per share, for a total transaction of $641,800.00. Following the transaction, the director owned 14,363 shares of the company’s stock, valued at approximately $921,817.34. This represents a 229.20% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO James Saccaro purchased 3,310 shares of the firm’s stock in a transaction dated Friday, May 1st. The stock was bought at an average cost of $60.60 per share, with a total value of $200,586.00. Following the purchase, the chief financial officer owned 87,471 shares of the company’s stock, valued at approximately $5,300,742.60. This trade represents a 3.93% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired a total of 21,847 shares of company stock valued at $1,361,355 over the last ninety days. 0.36% of the stock is currently owned by corporate insiders.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.